Genenta Science SPA GNTA:NASDAQ

RT Quote | USD
Last | 05/02/24 EDT
3.31UNCH (UNCH)
52 week range
2.20 - 6.81
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.31
  • 52 Week High6.81
  • 52 Week High Date06/13/23
  • 52 Week Low2.20
  • 52 Week Low Date04/24/24

Key Stats

  • Market Cap60.298M
  • Shares Out18.22M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta0.71
  • YTD % Change-33.13

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.31
  • 52 Week High6.81
  • 52 Week High Date06/13/23
  • 52 Week Low2.20
  • 52 Week Low Date04/24/24
  • Market Cap60.298M
  • Shares Out18.22M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta0.71
  • YTD % Change-33.13

RATIOS/PROFITABILITY

  • EPS (TTM)-0.71
  • P/E (TTM)-4.69
  • Fwd P/E (NTM)-3.68
  • EBITDA (TTM)-12.538M
  • ROE (TTM)-45.16%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Genenta Science SPA

 

Content From Our Affiliates

Profile

MORE
Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.
Stephen Squinto Ph.D.
Independent Chairman of the Board
Pierluigi Paracchi
Chief Executive Officer, Vice Chairman of the Board, General Manager
Richard Slansky
Chief Financial Officer
Address
Via Olgettina 58
Milano
20132
Italy